BidaskClub downgraded shares of Vitamin Shoppe, Inc (NYSE:VSI) from a hold rating to a sell rating in a report issued on Thursday.

A number of other equities analysts also recently issued reports on the company. Zacks Investment Research upgraded Vitamin Shoppe from a strong sell rating to a hold rating in a report on Tuesday, July 18th. ValuEngine cut Vitamin Shoppe from a buy rating to a hold rating in a research note on Friday, June 2nd. Barclays PLC reissued an equal weight rating and issued a $13.00 target price (down from $24.00) on shares of Vitamin Shoppe in a research note on Sunday, May 14th. Gabelli cut Vitamin Shoppe from a buy rating to a hold rating in a research note on Thursday, May 11th. Finally, Morgan Stanley raised Vitamin Shoppe from an underweight rating to an equal weight rating and set a $14.00 target price on the stock in a research note on Thursday, May 11th. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and one has given a buy rating to the stock. The company currently has a consensus rating of Hold and an average price target of $24.00.

Shares of Vitamin Shoppe (VSI) opened at 10.85 on Thursday. The firm has a market cap of $251.32 million, a P/E ratio of 13.96 and a beta of 0.69. The company has a 50-day moving average of $11.10 and a 200 day moving average of $16.85. Vitamin Shoppe has a 52-week low of $9.80 and a 52-week high of $29.56.

Vitamin Shoppe (NYSE:VSI) last posted its quarterly earnings data on Wednesday, May 10th. The specialty retailer reported $0.37 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.58 by $0.21. The firm had revenue of $316.90 million during the quarter, compared to the consensus estimate of $325.71 million. Vitamin Shoppe had a return on equity of 9.35% and a net margin of 1.43%. Vitamin Shoppe’s revenue for the quarter was down 5.9% compared to the same quarter last year. During the same quarter last year, the company posted $0.67 EPS. On average, equities analysts expect that Vitamin Shoppe will post $1.57 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: “Vitamin Shoppe, Inc (VSI) Downgraded by BidaskClub to “Sell”” was first reported by Watch List News and is the sole property of of Watch List News. If you are viewing this story on another site, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The legal version of this story can be viewed at https://www.watchlistnews.com/vitamin-shoppe-inc-vsi-downgraded-by-bidaskclub-to-sell/1463374.html.

Large investors have recently added to or reduced their stakes in the company. Arizona State Retirement System boosted its stake in Vitamin Shoppe by 0.8% in the first quarter. Arizona State Retirement System now owns 12,360 shares of the specialty retailer’s stock worth $249,000 after buying an additional 100 shares in the last quarter. Texas Permanent School Fund boosted its stake in Vitamin Shoppe by 0.8% in the second quarter. Texas Permanent School Fund now owns 17,389 shares of the specialty retailer’s stock worth $203,000 after buying an additional 145 shares in the last quarter. Mason Street Advisors LLC boosted its stake in Vitamin Shoppe by 7.0% in the first quarter. Mason Street Advisors LLC now owns 5,569 shares of the specialty retailer’s stock worth $112,000 after buying an additional 366 shares in the last quarter. Capstone Asset Management Co. boosted its stake in Vitamin Shoppe by 3.5% in the second quarter. Capstone Asset Management Co. now owns 14,040 shares of the specialty retailer’s stock valued at $164,000 after buying an additional 470 shares during the period. Finally, Thrivent Financial For Lutherans boosted its stake in Vitamin Shoppe by 1.5% in the first quarter. Thrivent Financial For Lutherans now owns 37,070 shares of the specialty retailer’s stock valued at $747,000 after buying an additional 560 shares during the period.

Vitamin Shoppe Company Profile

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Analyst Recommendations for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.